Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D

Bradford, Ashley; Bradford, W. David

doi:10.1377/hlthaff.2015.1661

Cited by 289 publications

(263 citation statements)

References 11 publications

Supporting

Mentioning

233

Contrasting

Order By: Relevance

“…This is an important area for future research as the interaction effects between cannabis and opioids have not been fully investigated. 30,31 Interestingly, some studies have found that jurisdictions where cannabis is available for therapeutic purposes tend to see a decrease in prescription opioid/pain medication use, 32,33 suggesting that some people with chronic pain may be using therapeutic cannabis as a substitute for prescription opioids. 34,35 This study also indicated that among those who reported CUTP, 15.2% reported that they had medical approval to use cannabis therapeutically.…”

Section: Discussionmentioning

confidence: 99%

Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada

Hamilton

Brands

Ialomiteanu

et al. 2017

Can J Public Health

View full text Add to dashboard Cite

OBJECTIVE: To investigate the prevalence of therapeutic cannabis use within a general population sample of adults and to describe various characteristics associated with use.METHODS: Data were derived from the 2013 and 2014 CAMH Monitor Survey of adults in Ontario, Canada. This repeated cross-sectional survey employed a regionally stratified design and utilized computer-assisted telephone interviewing. Analyses were based on 401 respondents who reported using cannabis. RESULTS:The data indicated that 28.8% of those who used cannabis in the past year self-reported using cannabis for therapeutic purposes. Of therapeutic users, 15.2% reported having medical approval to use cannabis for therapeutic purposes. Cannabis use for therapeutic purposes was associated with more frequent use of cannabis, a moderate to high risk of problematic cannabis use, and a greater likelihood of using prescription opioids for medical purposes. There was little difference in cannabis use for therapeutic purposes according to sex, age, and marital status after adjusting for opioid use and problematic cannabis use. CONCLUSION:Findings suggest some potential negative consequences of cannabis use for therapeutic purposes; however, further research is needed to better understand the range and patterns of use and their corresponding vulnerabilities.KEY WORDS: Medical cannabis use; medical marijuana use; prescription opioids; problematic cannabis use La traduction du résumé se trouve à la fin de l'article.

show abstract

Section: Discussionmentioning

confidence: 99%

Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada

Hamilton

Brands

Ialomiteanu

et al. 2017

Can J Public Health

View full text Add to dashboard Cite

show abstract

“…For example, when states regulate access to controlled substances, they are able to consider sample legislation available through the National Alliance for Model State Drug Laws. Standardized versions of state laws for policies like the medicinal use of marijuana allow researchers to conduct studies using categorizations of states, exploiting variations in the year of adoption to implement a study with a DID design (22,81).…”

Section: Policy Variation and Heterogeneitymentioning

confidence: 99%

Designing Difference in Difference Studies: Best Practices for Public Health Policy Research

Wing

Simon

Bello-Gómez

2024

Annual Review of Public Health

1,024

826

View full text Add to dashboard Cite

The difference in difference (DID) design is a quasi-experimental research design that researchers often use to study causal relationships in public health settings where randomized controlled trials (RCTs) are infeasible or unethical. However, causal inference poses many challenges in DID designs. In this article, we review key features of DID designs with an emphasis on public health policy research. Contemporary researchers should take an active approach to the design of DID studies, seeking to construct comparison groups, sensitivity analyses, and robustness checks that help validate the method's assumptions. We explain the key assumptions of the design and discuss analytic tactics, supplementary analysis, and approaches to statistical inference that are often important in applied research. The DID design is not a perfect substitute for randomized experiments, but it often represents a feasible way to learn about casual relationships. We conclude by noting that combining elements from multiple quasi-experimental techniques may be important in the next wave of innovations to the DID approach.

show abstract

“…Third, our findings contribute to the economic literature on policy spillover effects. Previous studies show that MMLs have spillover effects to public insurance programs (Bradford & Bradford, 2016. Moreover, there is a broader economic literature on policy spillovers.…”

mentioning

confidence: 99%

Marijuana legalization and disability claiming

MacLean

Ghimire

Nicholas

2017

View full text Add to dashboard Cite

We study the effect of state medical marijuana laws (MMLs) on Social Security Disability Insurance (SSDI) and Workers' Compensation (WC) claiming among working age adults. We use data on benet claiming drawn from the 1990 to 2013 Current Population Survey coupled with a differences-in-differences design to study this question. We nd that passage of an MML increases SSDI claiming. Post-MML the propensity to claim SSDI increases by 0.31 percentage points, which translates to 11.3% relative to SSDI claiming propensity in our sample (2.7%). Point estimates for WC are imprecise.

show abstract

Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D

Cited by 289 publications

References 11 publications

Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada

Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada

Designing Difference in Difference Studies: Best Practices for Public Health Policy Research

Marijuana legalization and disability claiming

Contact Info

Product

Resources

About